Skip to main content

Table 2 NSCLC distribution by histology

From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

  N = 173 (%)
Adenocarcinoma 91 (52)
Squamous cell 34 (20)
Poorly differentiated 17 (10)
Adeno-squamous 11 (6)
Non-small cell cancer 6 (3)
Large cell carcinoma 5 (3)
Carcinoma 5 (3)
Bronchoalveolar 2 (1)
Squamous cell-Small cell 1 (0.5)
Mucoepidermoid 1 (0.5)
  1. NSCLC: Non-small cell lung cancer.